Latest Asx Listing News

Freehill Mining Limited has increased its capital raising to $540,000 through a share placement and free-attaching options, aiming to support its processing operations in Chile and strengthen working capital.

Alligator Energy Limited has released its comprehensive company constitution, detailing governance, shareholder rights, and director responsibilities under Australian law and ASX rules. This foundational document sets the framework for the company’s operations and compliance.

Strategic Energy Resources (SER) has addressed recent unusual trading activity in its shares, attributing the price and volume spikes to external market factors while highlighting ongoing drilling projects in Queensland.

BMG Resources has addressed recent unusual trading activity, confirming no undisclosed material information and providing an update on its Bullabulling drilling program results.

Jindalee Lithium has launched an options offer linked to its recent Share Purchase Plan and placements, aiming to incentivize shareholders and raise capital for its lithium development projects. The options carry an exercise price of $0.825 and expire in late 2028.

Memphasys Limited has disclosed a $1.118 million liability linked to its FY24 R&D tax rebate following an ASX inquiry, while confirming compliance with continuous disclosure rules and ongoing engagement with the ATO for a private ruling.

European Lithium Limited has launched a replacement options offer for holders of 205 million expiring options, with directors committing to fully participate and underwrite the offer pending shareholder approval at the upcoming AGM.

Magmatic Resources has successfully raised A$3 million through a discounted placement, with major shareholder FMG Resources increasing its stake to nearly 20%. The funds will accelerate exploration at key copper and gold projects.

Power Minerals Limited is set to list on the US OTCQB market following strong investor interest after acquiring the Gamma Heavy Rare Earths and Uranium Project in California, aiming to boost liquidity and visibility in the US capital markets.

Vectus Biosystems has agreed to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics for US$3 million in shares and warrants, gaining a strategic equity position while refocusing on its cardiovascular and fibrosis pipeline.

DGL Group Limited has reported a larger-than-expected FY25 net loss following an increased goodwill impairment and received a Disclaimer of Opinion from its auditor due to inventory and control issues during a major ERP system rollout.

Zoono Group Limited has responded to an ASX price query following a recent surge in its share price and trading volume, confirming no undisclosed information exists and attributing market activity to ongoing shelf-life extension trials across multiple continents.